Head and Neck Cancer Trial, Recruiting NCT05658731 Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT05658731
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Stratum A (currently receiving radiation treatment):

  • You are between 1 and 25 years old
  • Your tumor is located in or near the brain, including areas such as the nasal cavity, sinuses, or eye socket
  • Your treatment plan includes radiation therapy (either proton or photon type)
  • You have not yet finished your radiation treatment

Stratum B (finished radiation treatment at least 2 years ago):

  • You were diagnosed with a brain tumor before the age of 26
  • You received radiation to the brain as part of your treatment
  • It has been at least 2 years since you started radiation treatment
  • Your tumor has not come back since your most recent radiation treatment

Stratum C (imaging study group):

  • You are between 5 and 25 years old
  • You are able to complete research brain scans without needing sedation (sleep-inducing medication)

Who may not be able to join:

Stratum A:

  • You are pregnant
  • You are unable to complete thinking and memory tests, including if English is not understood, or if you have a pre-existing condition affecting brain development such as Down's syndrome or autism

Stratum B:

  • You are unable to complete thinking and memory tests, including if English is not understood, or if you have a pre-existing condition affecting brain development such as Down's syndrome or autism

Stratum C:

  • You have a significant psychiatric, neurological, or other major medical diagnosis (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sahaja Acharya, MD, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phone: 202-537-4788

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
17 May 2023
Est. completion
1 December 2032

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of plans that meet substructure-informed planning constraints

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov